课题基金 / 基金详情

Influence of mannose receptor ubiquitination and TLR signaling on antigen translocation from endosomes into the cytoplasm for cross-presentation

Influence of mannose receptor ubiquitination and TLR signaling on antigen translocation from endosomes into the cytoplasm for cross-presentation
甘露糖受体泛素化和 TLR 信号传导对抗原从内体易位到细胞质进行交叉呈递的影响
批准号:
91058073
负责人:
Professor Dr. Sven Burgdorf
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2014-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For cross-presentation, antigens need to be transported from an endosomal compartment into the cytoplasm, a process that is only partially understood. In a first phase of this grant application, we demonstrated that poly-ubiquitination of the Mannose Receptor (MR), an endocytic receptor that targets its ligands specifically towards cross-presentation, is required for such antigen transport. Poly-ubiquitination of the MR mediated the recruitment of p97, an enzyme that provided the energy for antigen translocation, towards the endosomal membrane. Additionally, we identified TSG101 as a dominant negative inhibitor of MR poly-ubiquitination, p97 recruitment and antigen translocation into the cytosol, and hence as an important regulator of cross-presentation. Previous work by our group demonstrated that, after antigen transport into the cytoplasm and proteasomal degradation, antigenderived peptides are translocated by endosomal TAP into the same endosomes, where loading onto MHC I molecules occurs. Such spatial separation compared to MHC I presentation in the ER implies the use of a distinct set of proteasomes in direct proximity to such endosomes. Since p97 during dislocation at the ER recruits proteasomes towards the ER membrane, we would like to investigate in the second part of this proposal whether p97 mediates the recruitment of proteasome subunits also at the endosomal membrane and whether such recruitment is essential for cross-presentation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于细胞工厂的靶向人源硫酸化O-GalNAc/Mannose多糖组的扩增制备
  • 批准号:
    22307020
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    李中华
  • 依托单位:
Ferritin-Mannose纳米粒通过糖代谢影响乳腺癌放疗敏感性及其机制研究
  • 批准号:
    82073355
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2020
  • 负责人:
    冯国兴
  • 依托单位:
靶向结核杆菌细胞壁ManLAM的多肽型显像剂,用于鉴别诊断结核病灶与肿瘤病灶的实验研究
  • 批准号:
    30970859
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2009
  • 负责人:
    唐恭顺
  • 依托单位: